Oxford Nanopore
Oxford Nanopore Technologies was founded in 2005 to develop an electronic, single molecule sensing system based on nanopore science. The company now has around 900 employees from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialization. Oxford Nanopore's instruments are adaptable for the analysis of DNA, RNA, proteins, small molecules and other types of molecules.
Oxford Nanopore, Wasatch BioLabs Developing Direct Whole-Methylome Sequencing
The companies are developing a whole-methylome sequencing approach to address the limitations of existing DNA methylation analysis methods.
New Nanopore Sequencing Method Improves Clinical Genomic Breakpoint Detection, Carrier Screening
Premium
Developed by researchers in Saudi Arabia, NanoRanger deploys partial restriction digests, inverse PCR, and long-read sequencing for base-resolution breakpoint analysis.
Long-Read Sequencing Data Analysis Reveals Advanced Cancer Features
Researchers delved into data for 189 tumors sequenced in the "Long-Read Personalized OncoGenomics" project to ID complex structural variants and methylation marks, among other tumor insights.
People in the News at Illumina, Beckman Coulter, Oxford Nanopore, Quanterix, Akoya, Nuclera, More
Recently posted executive and academic appointments, promotions, and departures in omics and molecular diagnostics.
At least one company, Portal Biotech, has begun placing nanopore-based protein analyzers with early adopters as the field continues to tackle technical challenges.